Non-vasoconstricting energy-promoting compositions containing ketone bodies
An energy-promoting composition includes a stimulant component such as caffeine, a vasodilator component, an energy source including an exogenous ketone body component, and optionally a nootropic component. The separate components beneficially and synergistically interact with one another enhances the overall energy-promoting effect of the composition more rapidly and to a greater degree than if one or more of the components are omitted. The energy-promoting composition is also formulated to minimize the crash effect common to stimulants such as energy drinks.
1. An energy-promoting composition, comprising:
a stimulant component that interacts with at least one receptor to increase alertness;
a vasodilator component; and
an energy source that is metabolized in cells to provide energy comprising an exogenous ketone body component,
wherein the exogenous ketone body component comprises a mixed salt-acid including beta-hydroxybutyric acid and sodium ions and potassium ions, wherein the molar ratio of sodium ions to potassium ions is no greater than about 2.5.
2. The energy-promoting composition of claim 1 , wherein the stimulant component comprises caffeine in an amount ranging from about 30 mg to about 250 mg.
3. The energy-promoting composition of claim 1 , wherein the stimulant component comprises one or more adenosine receptor antagonists, phosphodiesterase inhibitors, epinephrine and/or norepinephrine promoters, or combinations thereof.
4. The energy-promoting composition of claim 1 , wherein the stimulant component comprises one or more xanthan alkaloids, wherein the one or more xanthan alkaloids comprises caffeine, theacrine, theobromine, theophylline, methylliberine, caffeine analogs, or combinations thereof.
5. The energy-promoting composition of claim 1 , wherein the vasodilator component comprises one or more of a nitric oxide promoter, an arginase inhibitor, and a nitric oxide synthase promoter.
6. The energy-promoting composition of claim 1 , wherein the vasodilator component comprises one or more of quercetin, L-citrulline and/or salt thereof, L-arginine and/or salt thereof, agmatine and/or salt thereof, nitrates, gallic acid, coenzyme Q10 (CoQ10), trimethylglycine, niacin, theanine, theobromine, garlic, magnesium, grape seed extract, green tea extract, catechins and/or epicatechins, cacao, proanthocyanidins, galloylated proanthocyanidins, L-norvaline, beta-alanine, glutathione, and taurine.
7. The energy-promoting composition of claim 6 , wherein the vasodilator component comprises epicatechin-(4-8)-epicatechin-(4-8)-epicatechin or epicatechin-(4-8)-epicatechin-(4-8)-epicatechin-gallate.
8. The energy-promoting composition of claim 1 , wherein the vasodilator component is included at a dose formulated to provide a vasodilating effect equal or substantially similar to a dose of about 1 g to about 8 g citrulline.
9. The energy-promoting composition of claim 1 , wherein the exogenous ketone body component comprises beta-hydroxybutyrate and/or acetoacetate each provided as a salt, ester, free acid, or combination thereof.
10. The energy-promoting composition of claim 1 , wherein the exogenous ketone body component is included in an amount ranging from about 0.5 g to about 20 g.
11. The energy-promoting composition of claim 1 , wherein the exogenous ketone body component comprises acetoacetic acid.
12. The energy-promoting composition of claim 1 , wherein the molar ratio of sodium ions to potassium ions is no greater than about 1.5.
13. The energy-promoting composition of claim 1 , wherein the composition omits glucose, fructose, and sucrose.
14. The energy-promoting composition of claim 1 , further comprising a nootropic component.
15. The energy-promoting composition of claim 14 , wherein the nootropic component comprises one or both of a dopamine promoter and an acetylcholine promoter.
16. The energy-promoting composition of claim 14 , wherein the nootropic component comprises one or more of methylliberine, theacrine, Mucuna pruriens , tyrosine, L-DOPA (i.e., L-3,4-dihydroxyphenylalanine), huperzine-A, dimethylaminoethanol, phenylalanine, phenylethylamine, choline, alpha-glycerophosphocholine, uridine, citicoline, a racetam, or a combination thereof.
17. The energy-promoting composition of claim 14 , wherein the nootropic component comprises one or more of tryptophan, 5-hydroxytryptophan (5-HTP), D-serine, phosphatidylserine, Panax ginseng, Ginkgo biloba, Rhodiola rosea, Polygala tenuifolia, Muira puama, Huperzia serrata, Eschscholzia californica, Convolvulus pluricaulis, Centella asiatica, Evolvulus alsinoides, Bacopa monnieri, Epimedium herbs, Ashwagandha herbs, forskolin, vinpocetine, or a combination thereof.
18. The energy-promoting composition of claim 1 , wherein the composition is formulated as a consumable liquid.
19. An energy-promoting composition, comprising:
a stimulant component;
a vasodilator component comprising at least one of epicatechin-(4-8)-epicatechin-(4-8)-epicatechin or epicatechin-(4-8)-epicatechin-(4-8)-epicatechin-gallate; and
an energy source comprising an exogenous ketone body component.
20. An energy-promoting composition, comprising:
a stimulant component selected from the group consisting of methylliberine, adenosine receptor antagonists, phosphodiesterase inhibitors, epinephrine and/or norepinephrine promoters, and xanthan alkaloids;
a vasodilator component;
a nootropic component separate from the stimulant component; and
an energy source that is metabolized in cells to provide energy comprising at least one exogenous ketone body component, wherein the exogenous ketone body component comprises a mixed salt-acid including beta-hydroxybutyric acid and sodium ions and potassium ions, wherein the molar ratio of sodium ions to potassium ions is no greater than about 2.5.
21. An energy-promoting composition, comprising:
a stimulant component selected from the group consisting of caffeine, theacrine, theobromine, theophylline, methylliberine;
a vasodilator component;
a nootropic component selected from the group consisting of Mucuna pruriens , tyrosine, L-DOPA (i.e., L-3,4-dihydroxyphenylalanine), huperzine-A, dimethylaminoethanol, phenylalanine, phenylethylamine, choline, alpha-glycerophosphocholine, uridine, citicoline, tryptophan, 5-hydroxytryptophan (5-HTP), D-serine, phosphatidylserine, Panax ginseng, Ginkgo biloba, Rhodiola rosea, Polygala tenuifolia, Muira puama, Huperzia serrata, Eschscholzia californica, Convolvulus pluricaulis, Centella asiatica, Evolvulus alsinoides, Bacopa monnieri, Epimedium herbs, Ashwagandha herbs, forskolin, vinpocetine, and combinations; and
one or more exogenous ketone body components comprising a mixed salt-acid, the mixed salt-acid including beta-hydroxybutyric acid and sodium ions and potassium ions, wherein the molar ratio of sodium ions to potassium ions is no greater than about 2.5.